Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritusJonathan I. Silverberg, Alan Clucas, Lisa Lindsey et al.|Journal of Allergy and Clinical Immunology|2019Cited by 268